Follow
Robert J Commons
Robert J Commons
Menzies School of Health Research
Verified email at wwarn.org
Title
Cited by
Cited by
Year
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
ATTACC, ACTIV-4a, and REMAP-CAP Investigators
New England Journal of Medicine 385 (9), 790-802, 2021
9992021
Interleukin-6 receptor antagonists in critically ill patients with Covid-19
Remap-Cap Investigators
New England Journal of Medicine 384 (16), 1491-1502, 2021
5922021
Plasmodium vivax in the era of the shrinking P. falciparum map
RN Price, RJ Commons, KE Battle, K Thriemer, K Mendis
Trends in parasitology 36 (6), 560-570, 2020
1592020
Streptococcal superantigens: categorization and clinical associations
RJ Commons, PR Smeesters, T Proft, JD Fraser, R Robins-Browne, ...
Trends in molecular medicine 20 (1), 48-62, 2014
1402014
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta …
RJ Commons, JA Simpson, K Thriemer, GS Humphreys, T Abreha, ...
The Lancet Infectious Diseases 18 (9), 1025-1034, 2018
1112018
Superantigen genes in group A streptococcal isolates and their relationship with emm types
R Commons, S Rogers, T Gooding, M Danchin, J Carapetis, ...
Journal of medical microbiology 57 (10), 1238-1246, 2008
982008
Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections
S Rogers, R Commons, MH Danchin, G Selvaraj, L Kelpie, N Curtis, ...
The Journal of infectious diseases 195 (11), 1625-1633, 2007
922007
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ...
Intensive care medicine 47, 867-886, 2021
862021
Estimating the proportion of Plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis
RJ Commons, JA Simpson, J Watson, NJ White, RN Price
The American journal of tropical medicine and hygiene 103 (3), 1094, 2020
842020
Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial
S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ...
Jama 329 (1), 39-51, 2023
802023
Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis
RJ Commons, JA Simpson, K Thriemer, MS Hossain, NM Douglas, ...
The Lancet Infectious Diseases 19 (1), 91-101, 2019
772019
Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
CA Bradbury, PR Lawler, SJ Stanworth, BJ McVerry, Z McQuilten, ...
Jama 327 (13), 1247, 2022
752022
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group
K Thriemer, B Ley, A Bobogare, L Dysoley, MS Alam, AP Pasaribu, ...
Malaria journal 16, 1-9, 2017
722017
High burden of diabetic foot infections in the top end of Australia: an emerging health crisis (DEFINE study)
RJ Commons, CH Robinson, D Gawler, JS Davis, RN Price
Diabetes research and clinical practice 110 (2), 147-157, 2015
662015
Therapeutic anticoagulation in critically ill patients with Covid-19–preliminary report
REMAP-CAP, ACTIV-4a, ATTACC Investigators, R Zarychanski
MedRxiv, 2021.03. 10.21252749, 2021
512021
Genetic diversity of the msp-1, msp-2, and glurp genes of Plasmodium falciparum isolates in Northwest Ethiopia
H Mohammed, M Kassa, K Mekete, A Assefa, G Taye, RJ Commons
Malaria journal 17, 1-8, 2018
472018
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance …
RJ Commons, JA Simpson, K Thriemer, CS Chu, NM Douglas, T Abreha, ...
BMC medicine 17, 1-13, 2019
382019
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance …
MS Hossain, RJ Commons, NM Douglas, K Thriemer, BH Alemayehu, ...
PLoS medicine 17 (11), e1003393, 2020
362020
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and …
RJ Commons, JA Simpson, K Thriemer, T Abreha, I Adam, NM Anstey, ...
PLoS medicine 16 (10), e1002928, 2019
342019
Twenty‐six years of enteric fever in Australia: an epidemiological analysis of antibiotic resistance
RJ Commons, E McBryde, M Valcanis, J Powling, A Street, G Hogg
Medical journal of Australia 196 (5), 332-336, 2012
342012
The system can't perform the operation now. Try again later.
Articles 1–20